Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 26-4440871 · Snapshot of IRS recognition, filing currency, financial health, and governance.
Conduct Research and development to further biomedical innovations on stem cells and reprogrammed cells for potential therapy
Principal Officer
David Tan-Shei Wu
Total Revenue
$0
FY2023
Total Expenses
$0
FY2023
Net Assets
$6K
Program Ratio
—
expenses on programs
Employees
0
Volunteers
—
Board Members
0
Voting
0
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.